RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
REGENTIS BIOMATERIALS LTD.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026
$1.48−0.01 (-0.67%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Regentis Biomaterials has not reported a dividend
No dividend per share appears in Regentis Biomaterials's annual filings since fiscal 2022.